Please wait a minute...
Journal of Neurorestoratology  2017, Vol. 5 Issue (1): 111-115    doi: 10.2147/JN.S132589
2016 yearbook of neurorestoratology
Hongyun Huang1,2, Gengsheng Mao1, Shiqing Feng3, Lin Chen2,4
1 Institute of Neurorestoratology, General Hospital of Armed Police Forces;
2 Cell Therapy Center, Beijing Hongtianji Neuroscience Academy, Beijing;
3 Department of Orthopedic, Tianjin Medical University General Hospital, Tianjin;
4 Department of Neurosurgery, Tsinghua University Yuquan Hospital, Beijing, People’s Republic of China
Download: PDF (123 KB)     
Export: BibTeX | EndNote (RIS)      

Abstract  Neurorestoratology, a new interdisciplinary field, has gradually become a popular clinical discipline. Physicians and scientists in the neurorestoration field have discovered new pathogeneses of nervous system diseases and damage, explored new neurorestorative mechanisms, and obtained improving neurorestorative effects in clinical trials (or therapies). This paper summarizes the major progress achieved over the past year.

Key wordsyearbook      neurorestoratology      pathogenesis      neural repair and regeneration      central nervous system disease      neurorestorative mechanisms      neurorestorative strategies     
Received: 17 January 2017      Published: 26 December 2017
Corresponding Authors: Hongyun Huang , Institute of Neurorestoratology, General Hospital of Armed Police Forces, No 69 Rongding Road, Beijing 100039, People’s Republic of China Tel +86 139 1011 6608 Email   
Cite this article:

Hongyun Huang, Gengsheng Mao, Shiqing Feng, Lin Chen. 2016 yearbook of neurorestoratology. Journal of Neurorestoratology, 2017, 5: 111-115.

URL:     OR

1. Huang H, Chen L.Neurorestoratology—new subject, new principle, new field in 21st century.J Repar Reconstr Surg. 2008;22:439-445.
2. Chen L, Huang H.Neurorestoratology: new concept and bridge from bench to bedside.Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2009;23:366-370.
3. Huang H, Sharma H.Neurorestoratology: one of the most promising new disciplines at the forefront of neuroscience and medicine.J Neurorestoratol. 2013;1:37-41.
4. Huang L, Chen L.Neurorestoratology: a concept and emerging discipline in the treatment of neurological disorders.CNS Neurol Disord Drug Targets. 2016;15(5):522-525.
5. IANR (International Association of Neurorestoratology). Beijing declaration of international association of neurorestoratology (IANR).Cell Transplant. 2009;18:487.
6. Gao J, Thonhoff JR, Dunn TJ, Wu P.Lipoic acid enhances survival of transplanted neural stem cells by reducing transplantation-associated injury.J Neurorestoratol. 2013;1:1-12.
7. Young W, AlZoubi Z, Saberi H, et al. Beijing declaration of international association of neurorestoratology (IANR).J Neurorestoratol. 2015,3:121-122.
8. Cajal SRY.Degeneration and Regeneration of the Nervous System (May RM, Trans.). London: Oxford University Press; 1928.
9. Huang H, Chen L, Sanberg PR.Clinical achievements, obstacles, falsehoods, and future directions of cell-based neurorestoratology.Cell Transplant. 2012;21(Suppl 1):S3-S11.
10. Huang H, Sun T, Chen L, et al.Consensus of clinical neurorestorative progress in patients with complete chronic spinal cord injury.Cell Transplant. 2014;23(Suppl 1):S5-S17.
11. Huang H, Chen L.Neurorestorative process, law, and mechanisms.J Neurorestoratol. 2015;3:23-30.
12. Huang H. CNS Neurorestoratology.Beijing: Science Press; 2009.
13. Huang H, Raisman G, Sanberg PR, Sharma H, Chen L.Neurorestoratology. New York, NY: Nova Biomedical; 2015.
14. Glasser MF, Coalson TS, Robinson EC, et al.A multi-modal parcellation of human cerebral cortex.Nature. 2016;536(7615):171-178.
15. Huth AG, de Heer WA, Griffiths TL, Theunissen FE, Gallant JL. Natural speech reveals the semantic maps that tile human cerebral cortex.Nature. 2016;532(7600):453-458.
16. Balsters JH, Mantini D, Apps MA, Eickhoff SB, Wenderoth N.Connectivity-based parcellation increases network detection sensitivity in resting state fMRI: An investigation into the cingulate cortex in autism.Neuroimage Clin. 2016;11:494-507.
17. Kamat PK, Kalani A, Rai S, et al.Mechanism of oxidative stress and synapse dysfunction in the pathogenesis of alzheimer’s disease: understanding the therapeutics strategies.Mol Neurobiol. 2016;53(1):648-661.
18. Sekar A, Bialas AR, de Rivera H, et al; Schizophrenia Working Group of the Psychiatric Genomics Consortium. Schizophrenia risk from complex variation of complement component 4.Nature. 2016;530(7589):177-183.
19. Hong S, Beja-Glasser VF, Nfonoyim BM, et al.Complement and microglia mediate early synapse loss in Alzheimer mouse models.Science. 2016;352(6286):712-716.
20. Lui H, Zhang J, Makinson SR, et al.Progranulin deficiency promotes circuit-specific synaptic pruning by microglia via complement activation.Cell. 2016;165(4):921-935.
21. Kumar DK, Choi SH, Washicosky KJ, et al. Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease. Sci Transl Med.2016;8(340):340ra72.
22. Hjerpe R, Bett JS, Keuss MJ, et al.UBQLN2 mediates autophagy-independent protein aggregate clearance by the proteasome.Cell. 2016;166(4):935-949.
23. Kandul NP, Zhang T, Hay BA, Guo M.Selective removal of deletion-bearing mitochondrial DNA in heteroplasmic Drosophila.Nat Commun. 2016;7:13100.
24. García Santos JM, Inuggi A, Gómez Espuch J, et al.Spinal cord infusion of stem cells in amyotrophic lateral sclerosis: magnetic resonance spectroscopy shows metabolite improvement in the precentral gyrus.Cytotherapy. 2016;18(6):785-796.
25. Oh YS, Kim SH, Cho GW.Functional restoration of amyotrophic lateral sclerosis patient-derived mesenchymal stromal cells through inhibition of DNA Methyltransferase.Cell Mol Neurobiol. 2016;36(4):613-620.
26. Huang H, Mao G, Chen L, Liu A.Progress and challenges with clinical cell therapy in neurorestoratology.J Neurorestoratol. 2015;3:91-95.
27. Kalladka D, Sinden J, Pollock K, et al.Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study.Lancet. 2016;388(10046):787-796.
28. Steinberg GK, Kondziolka D, Wechsler LR, et al.Clinical outcomes of transplanted modified bone marrow-derived mesenchymal stem cells in stroke: a phase 1/2a study.Stroke. 2016;47(7):1817-1824.
29. Chernykh ER, Shevela EY, Starostina NM, et al.Safety and therapeutic potential of M2 macrophages in stroke treatment.Cell Transplant. 2016;25(8):1461-1471.
30. Zhu H, Poon W, Liu Y, et al.Phase III clinical trial assessing safety and efficacy of umbilical cord blood mononuclear cell transplant therapy of chronic complete spinal cord injury.Cell Transplant. 2016;25(11):1925-1943.
31. Kakabadze Z, Kipshidze N, Mardaleishvili K, et al.Phase 1 trial of autologous bone marrow stem cell transplantation in patients with spinal cord injury.Stem Cells Int. 2016;2016:6768274.
32. Vaquero J, Zurita M, Rico MA, et al; Neurological Cell Therapy Group. An approach to personalized cell therapy in chronic complete paraplegia: the Puerta de Hierro phase I/II clinical trial.Cytotherapy. 2016;18(8):1025-1036.
33. Thakkar UG, Vanikar AV, Trivedi HL, et al.Infusion of autologous adipose tissue derived neuronal differentiated mesenchymal stem cells and hematopoietic stem cells in post-traumatic paraplegia offers a viable therapeutic approach.Adv Biomed Res. 2016;5:51.
34. Wang S, Lu J, Li YA, et al.Autologous olfactory lamina propria transplantation for chronic spinal cord injury: three-year follow-up outcomes from a prospective double-blinded clinical trial.Cell Transplant. 2016;25(1):141-157.
35. Nafissi S, Kazemi H, Tiraihi T, et al.Intraspinal delivery of bone marrow stromal cell-derived neural stem cells in patients with amyotrophic lateral sclerosis: a safety and feasibility study.J Neurol Sci. 2016;362:174-181.
36. Petrou P, Gothelf Y, Argov Z, et al.Safety and clinical effects of mesenchymal stem cells secreting neurotrophic factor transplantation in patients with amyotrophic lateral sclerosis: results of phase 1/2 and 2a clinical trials. JAMA Neurol.2016;73(3):337-344.
37. Atkins HL, Bowman M, Allan D, et al.Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial.Lancet. 2016;388(10044):576-585.
38. Canesi M, Giordano R, Lazzari L, et al.Finding a new therapeutic approach for no-option parkinsonisms: mesenchymal stromal cells for progressive supranuclear palsy.J Transl Med. 2016;14(1):127.
39. Cox CS Jr, Hetz RA, Liao GP, et al.Treatment of severe adult traumatic brain injury using bone marrow mononuclear cells.Stem Cells. 2017;35(4):1065-1079.
40. Vaquero J, Zurita M, Bonilla C, et al.Progressive increase in brain glucose metabolism after intrathecal administration of autologous mesenchymal stromal cells in patients with diffuse axonal injury.Cytotherapy. 2017;19(1):88-94.
41. Xi HT, Chen D.Cell-based neurorestorative therapy for postpoliomyelitis syndrome: a case report.J Neurorestoratology. 2016,4:45-50.
42. Ren WQ, Yin F, Zhang JN, et al.Neural stem cell transplantation for the treatment of primary torsion dystonia: a case report.Exp Ther Med. 2016;12(2):661-666.
43. Bouton CE, Shaikhouni A, Annetta NV, et al.Restoring cortical control of functional movement in a human with quadriplegia.Nature. 2016;533(7602):247-250.
44. Vansteensel MJ, Pels EG, Bleichner MG, et al.Fully implanted brain-computer interface in a locked-in patient with ALS.N Engl J Med. 2016;375(21):2060-2066.
45. Flesher SN, Collinger JL, Foldes ST, et al. Intracortical microstimulation of human somatosensory cortex. Sci Transl Med.2016;8(361):361ra141.
46. Donati AR, Shokur S, Morya E, et al.Long-term training with a brain-machine interface-based gait protocol induces partial neurological recovery in paraplegic patients.Sci Rep. 2016;6:30383.
47. Carlsson CA, Sundin T.Reconstruction of efferent pathways to the urinary bladder in a paraplegic child.Rev Surg. 1967;24(1):73-76.
48. Tuite GF, Homsy Y, Polsky EG, et al.Urological outcome of the xiao procedure in children with myelomeningocele and lipomyelomeningocele undergoing spinal cord detethering.J Urol. 2016;196(6):1735-1740.
49. Yang W, Porras JL, Xu R, et al.Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome.Neurosurgery. 2016;63(Suppl 1):178.
50. Mohamed A, Omi E, Honda K, Suzuki S, Ishikawa K.Outcome of different facial nerve reconstruction techniques.Braz J Otorhinolaryngol. 2016;82(6):702-709.
51. Kochhar A, Albathi M, Sharon JD, Ishii LE, Byrne P, Boahene KD.Transposition of the intratemporal facial to hypoglossal nerve for reanimation of the paralyzed face: The VII to XII transposition technique. JAMA Facial Plast Surg.2016;18(5):370-378.
52. Sprigg N, O’Connor R, Woodhouse L, et al. Granulocyte colony stimulating factor and physiotherapy after stroke: results of a feasibility randomised controlled trial: stem cell trial of recovery EnhanceMent after stroke-3 (STEMS-3 ISRCTN16714730).PLoS One. 2016;11(9):e0161359.
53. Shin YK, Cho SR.Exploring erythropoietin and G-CSF combination therapy in chronic stroke patients.Int J Mol Sci. 2016;17(4):463.
54. Zhao H, Yun W, Zhang Q, et al.Mobilization of circulating endothelial progenitor cells by dl-3-n-Butylphthalide in acute ischemic stroke patients.J Stroke Cerebrovasc Dis. 2016;25(4):752-760.
[1] Hongyun Huang, Lin Chen, Gengsheng Mao, John Bach, Qun Xue, Fabin Han, Xiaoling Guo, Ali Otom, Elena Chernykh, Edgardo Alvarez, Andrey Bryukhovetskiy, Anna Sarnowaska, Xijing He, Milan Dimitrijevic, Ihsan Shanti, Klaus von Wild, Almudena Ramón-Cueto, Ziad Alzoubi, Gustavo Moviglia, Hamid Mobasheri, Adeeb Alzoubi, Wenchuan Zhang. The 2019 yearbook of Neurorestoratology[J]. Journal of Neurorestoratology, 2020, 8(1): 1-11.
[2] Xiaoling Guo, Xin Wang, Yan Li, Bo Zhou, Weidong Chen, Lihua Ren. Olfactory ensheathing cell transplantation improving cerebral infarction sequela: a case report and literature review[J]. Journal of Neurorestoratology, 2019, 7(2): 82-88.
[3] Lin Chen, Wise Young, Gustavo A. Moviglia, Ziad M. Al Zoubi. Summary report of the 11th Annual Conference of International Association of Neurorestoratology (IANR)[J]. Journal of Neurorestoratology, 2019, 7(1): 1-7.
[4] Hongyun Huang, Hari Shanker Sharma, Lin Chen, Hooshang Saberi, Gengsheng Mao. 2018 Yearbook of Neurorestoratology[J]. Journal of Neurorestoratology, 2019, 7(1): 8-17.
[5] Zikuan Leng, Nikhit Kethidi, Allen J. Chang, Lijun Sun, Jingjing Zhai, Yiting Yang, Jianzhong Xu, Xijing He. Muse cells and Neurorestoratology[J]. Journal of Neurorestoratology, 2019, 7(1): 18-25.
[6] Hongyun Huang, Stephen Skaper, Gengsheng Mao, Hooshang Saberi, Shiqing Feng, Sang Ryong Jeon, Lin Chen, Milan Dimitrijevic. 2017 Yearbook of Neurorestoratology[J]. Journal of Neurorestoratology, 2018, 6(1): 67-73.
[7] Qiang Ao, Juan Xiao, Yanqiu Yu, Gengsheng Mao, Qingyan Zou, Wenyong Gao, Hongyun Huang. Standards for the culture and quality control of umbilical cord mesenchymal stromal cells for neurorestorative clinical application (2017)[J]. Journal of Neurorestoratology, 2018, 6(1): 11-15.
[8] Gengsheng Mao, Yunliang Wang, Xiaoling Guo, Jun Liu, Zuncheng Zheng, Lin Chen. Neurorestorative effect of olfactory ensheathing cells and Schwann cells by intranasal delivery for patients with ischemic stroke: design of a multicenter randomized double-blinded placebo-controlled clinical study[J]. Journal of Neurorestoratology, 2018, 6(1): 74-80.
[9] Zhongju Shi, Zhijian Wei, Shiqing Feng, Gustavo Moviglia, Lin Chen, Ping Wu. Highlights for the 10th Annual Conference of the International Association of Neurorestoratology[J]. Journal of Neurorestoratology, 2018, 6(1): 84-87.
[10] Shiqing Feng, Juan Xiao, Fabin Han, Lin Chen, Wenyong Gao, Gengsheng Mao, Hongyun Huang. Neurorestorative clinical application standards for the culture and quality control of neural progenitor/precursor cells (version 2017)[J]. Journal of Neurorestoratology, 2018, 6(1): 115-119.
[11] Hongyun Huang, Hari Shanker Sharma, Lin Chen, Ali Otom, Ziad M. Al Zoubi, Hooshang Saberi, Dafin F. Muresanu, Xijing He. Review of clinical neurorestorative strategies for spinal cord injury: Exploring history and latest progresses[J]. Journal of Neurorestoratology, 2018, 6(1): 171-178.
[12] Juan Xiao, Lin Chen, Gengsheng Mao, Wenyong Gao, Ming Lu, Xijing He, Hongyun Huang. Neurorestorative clinical application standards for the culture and quality control of olfactory ensheathing cells[J]. Journal of Neurorestoratology, 2017, 5(1): 175-179.
[13] Xiang Li, Guangsheng Li, Keith Dip-Kei Luk, Yong Hu. Neurorestoratology evidence in an animal model with cervical spondylotic myelopathy[J]. Journal of Neurorestoratology, 2017, 5(1): 21-29.
[14] Yaping Feng, Tiansheng Sun, Lin Chen, Jiaxin Xie, Zhicheng Zhang, Hongyun Huang, Xijing He. Clinical therapeutic guideline for neurorestoration in spinal cord injury (Chinese version 2016)[J]. Journal of Neurorestoratology, 2017, 5(1): 73-83.
[15] Hongyun Huang, Lin Chen. Neurorestorative process, law, and mechanisms[J]. Journal of Neurorestoratology, 2015, 3(1): 23-30.